These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10807960)

  • 1. Moxonidine, a selective imidazoline-1 receptor agonist, suppresses the effects of ethanol withdrawal on the acoustic startle response in rats.
    Vandergriff J; Kallman MJ; Rasmussen K
    Biol Psychiatry; 2000 May; 47(10):874-9. PubMed ID: 10807960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the selective I1 imidazoline receptor agonist, moxonidine, on gastric secretion and gastric mucosal injury in rats.
    Glavin GB; Smyth DD
    Br J Pharmacol; 1995 Feb; 114(4):751-4. PubMed ID: 7773534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective antihypertensive action of moxonidine is mediated mainly by I1-imidazoline receptors in the rostral ventrolateral medulla.
    Haxhiu MA; Dreshaj I; Schäfer SG; Ernsberger P
    J Cardiovasc Pharmacol; 1994; 24 Suppl 1():S1-8. PubMed ID: 7533221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moxonidine for tramadol withdrawal symptoms during detoxification.
    Talih F; Ghossoub E
    BMJ Case Rep; 2015 Jul; 2015():. PubMed ID: 26156837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responding to acoustic startle during chronic ethanol intoxication and withdrawal.
    Rassnick S; Koob GF; Geyer MA
    Psychopharmacology (Berl); 1992; 106(3):351-8. PubMed ID: 1570382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agmatine, an endogenous imidazoline receptor ligand modulates ethanol anxiolysis and withdrawal anxiety in rats.
    Taksande BG; Kotagale NR; Patel MR; Shelkar GP; Ugale RR; Chopde CT
    Eur J Pharmacol; 2010 Jul; 637(1-3):89-101. PubMed ID: 20394743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotropin-releasing factor (CRF) and α 2 adrenergic receptors mediate heroin withdrawal-potentiated startle in rats.
    Park PE; Vendruscolo LF; Schlosburg JE; Edwards S; Schulteis G; Koob GF
    Int J Neuropsychopharmacol; 2013 Sep; 16(8):1867-75. PubMed ID: 23590881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presynaptic imidazoline receptors and alpha 2-adrenoceptors in the human heart: discrimination by clonidine and moxonidine.
    Likungu J; Molderings GJ; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):689-92. PubMed ID: 8938671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic effect of the selective I1-imidazoline receptor modulator moxonidine on ouabain-induced cardiac arrhythmia in guinea pigs.
    Mest HJ; Thomsen P; Raap A
    Ann N Y Acad Sci; 1995 Jul; 763():620-33. PubMed ID: 7677382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why imidazoline receptor modulator in the treatment of hypertension?
    Schäfer SG; Kaan EC; Christen MO; Löw-Kröger A; Mest HJ; Molderings GJ
    Ann N Y Acad Sci; 1995 Jul; 763():659-72. PubMed ID: 7677385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of moxonidine, an I1-imidazoline receptor agonist.
    Ziegler D; Haxhiu MA; Kaan EC; Papp JG; Ernsberger P
    J Cardiovasc Pharmacol; 1996; 27 Suppl 3():S26-37. PubMed ID: 8872297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. I1 imidazoline agonists. General clinical pharmacology of imidazoline receptors: implications for the treatment of the elderly.
    Prichard BN; Graham BR
    Drugs Aging; 2000 Aug; 17(2):133-59. PubMed ID: 10984201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The startle response in rats: effect of ethanol.
    Pohorecky LA; Cagan M; Brick J; Jaffe SL
    Pharmacol Biochem Behav; 1976 Mar; 4(3):311-6. PubMed ID: 6973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites.
    Ernsberger P; Damon TH; Graff LM; Schäfer SG; Christen MO
    J Pharmacol Exp Ther; 1993 Jan; 264(1):172-82. PubMed ID: 8380858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin-1A antagonists attenuate the effects of nicotine withdrawal on the auditory startle response.
    Rasmussen K; Kallman MJ; Helton DR
    Synapse; 1997 Oct; 27(2):145-52. PubMed ID: 9266775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. I1-imidazoline-receptor agonists in the treatment of hypertension: an appraisal of clinical experience.
    Ollivier JP; Christen MO
    J Cardiovasc Pharmacol; 1994; 24 Suppl 1():S39-48. PubMed ID: 7533226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acoustic startle reactivity during acute alcohol withdrawal in rats that differ in genetic predisposition toward alcohol drinking: effect of stimulus characteristics.
    Chester JA; Blose AM; Froehlich JC
    Alcohol Clin Exp Res; 2004 May; 28(5):677-87. PubMed ID: 15166641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of moxonidine and clonidine on potassium excretion in Sprague-Dawley rats.
    Hohage H; Mehrens T; Matzkies F; Steinmetz M; Greven J
    Pharmacol Res; 1999 May; 39(5):357-61. PubMed ID: 10328993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent.
    Prichard BN; Owens CW; Graham BR
    J Hum Hypertens; 1997 Aug; 11 Suppl 1():S29-45. PubMed ID: 9321737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective stimulation of I1-imidazoline receptors as a novel mechanism for antihypertensive action. Focus on moxonidine.
    Papp JG; Ollivier JP
    J Cardiovasc Pharmacol; 1994; 24 Suppl 1():v-vi. PubMed ID: 7533220
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.